DKFZ

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is a biomedical research institute located in Heidelberg, Germany. Founded in 1964, the DKFZ is one of the leading cancer research centers in the world. It is a member of the Helmholtz Association of German Research Centres and conducts research in the field of oncology and tumor biology.

The DKFZ was established to focus on understanding the molecular mechanisms of cancer and developing new cancer treatments. The research at the DKFZ is focused on understanding the genetic and molecular basis of cancer, developing new cancer therapies, and improving cancer diagnosis and treatment. The center's research includes the application of cutting-edge technologies such as genomics, epigenomics, and high-throughput sequencing to analyze cancer cells and identify potential targets for therapy.

The DKFZ collaborates with other leading research institutions and healthcare organizations around the world to advance cancer research and to translate the discovery of new cancer therapies into practical application. The center's expertise includes various areas, such as tumor biology, cancer genetics, and molecular imaging. The DKFZ has contributed to several breakthroughs in cancer research and has developed new treatments for various types of cancer.

As a leading cancer research center, the DKFZ has a robust scientific reputation, with over 60% of its publications listed in the top-tier scientific journals. The center's research is often funded by the European Union's Framework Programmes and other national and international funding agencies. With its expertise in cancer research and its commitment to interdisciplinary collaboration, the DKFZ plays a significant role in advancing cancer research and improving cancer treatment options.